Incruse Ellipta

Generic name: Umeclidinium
Drug class: Anticholinergic bronchodilators

Usage of Incruse Ellipta

Incruse Ellipta is an anticholinergic that works by relaxing muscles in the airways to improve breathing.

Incruse Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease, including bronchitis and emphysema.

Incruse Ellipta is for use only in people with COPD and should not be used to treat asthma.

Incruse Ellipta side effects

Get emergency medical help if you have signs of an allergic reaction to Incruse Ellipta: hives, rash, severe itching; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

wheezing, choking, or other breathing problems after using this medicine;

blurred vision, nausea, vomiting, eye pain or redness, or seeing halos or bright colors around lights; or

painful or difficult urination, or urinating more often.

Common Incruse Ellipta side effects may include:

cold symptoms such as stuffy nose, sneezing, sore throat, cough;

fast or irregular heartbeats;

bruising, darkened skin;

mouth pain, tooth pain;

muscle or joint pain;

stomach pain; or

altered sense of taste.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Incruse Ellipta

You should not use Incruse Ellipta if you are allergic to umeclidinium, or if you have:

a severe allergy to milk proteins.

To make sure Incruse Ellipta is safe for you, tell your doctor if you have:

glaucoma;

heart disease;

an enlarged prostate; or

urination problems.

Tell your doctor if you are pregnant or breastfeeding.

Incruse Ellipta is not approved for use by anyone younger than 18 years old.

Relate drugs

How to use Incruse Ellipta

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

1 inhalation (62.5 mcg) orally once a day Maximum dose: 1 inhalation every 24 hours Use: Treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema

Warnings

You should not use Incruse Ellipta if you are allergic to umeclidinium or have a severe allergy to milk proteins.

Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.

Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

What other drugs will affect Incruse Ellipta

Tell your doctor about all your other medicines, especially:

atropine;

medicine to treat depression, anxiety, mood disorders, or mental illness;

cold or allergy medicine (Benadryl and others);

medicine to treat Parkinson's disease;

medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

medicine to treat overactive bladder; or

another bronchodilator medication.

This list is not complete. Other drugs may interact with umeclidinium, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.